US Digital Therapeutics Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Data

The US Digital Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global US Digital Therapeutics market. This report explores all the key factors affecting the growth of the global US Digital Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141783/

Report Description of the US Digital Therapeutics Market Analysis

Research Scope and Assumption

The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off

Reason to buy the report:

Facilitate decision-making based on strong current and forecast data for US Digital Therapeutics Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the US Digital Therapeutics Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

US Digital Therapeutics Market Analysis Executive Summary

The U.S. digital therapeutics market size was valued at USD 1.05 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 22.2% from 2020 to 2027. Digital Therapeutics (DTx) deliver a wide range of services, encouraging users to adopt healthy habits and efficiently track and manage their health conditions which is increasing the demand. Continuously changing digital landscape and outbreak COVID 19 pandemic has led to an increase in the adoption. Furthermore, increased use of the internet and smartphones is one of the major factors driving the market growth.

Market Size and Key Findings

The US Digital Therapeutics Market Analysis size stood at around USD 1.34 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 22.2% during the forecast period.

The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period. Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics.

Market Dynamics

Market Growth Drivers Analysis

Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage and avert a broad spectrum of behavioural, mental and physical disorders. They are utilized alone or mix with medications, devices or other therapies to optimize patient care and health outcomes. Rising remote access to therapies that are clinically tested as safe and effective is one of the properties of digital therapeutics (DTx) during the treatment.

The technological advancement which the companies make in order to grow their product line and gain profits are one of the drivers for the growth of the digital therapeutic (DTx) market. The collaboration between the companies will help in the growth of the market and will act as an opportunity for the digital therapeutic (DTx) market.

The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the digital therapeutic (DTx) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Market Restraints

The privacy concerns related to digital therapeutic (DTx) apps may act as a restraint for the growth of the digital therapeutic (DTx) market. The quality of digital therapeutic (DTx) is to be maintained in order to provide better treatment and proper care for the customers, hence, this needs to be done correctly, therefore this would act as challenge for the digital therapeutic (DTx) market because many a times the need is not met.

COVID-19 impact on "US Digital Therapeutics Market Analysis

The demand has been increased after the nationwide lockdown due to covid-19. According to the KFF tracking poll in March 2020, around 47% of Americans staying at home have reported negative mental health effects. Out of them, over 21% have reported a major negative impact on their mental health. The FDA has released new guidelines for the computerized behavioral therapy and other DTx solutions during this public health emergency which is expected to fuel the growth.

Competitive Landscape

Key Players

The digital therapeutic (DTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companys focus related to digital therapeutic (DTx) market.

The major players covered in the North America digital therapeutic (DTx) market report are Fitbit, Inc., Livongo, ResMed, Omada Health, Inc., Noom, Inc., Happify, Inc., Welldoc, Inc., SAMSUNG, ATENTIV, MANGO HEALTH, CogniFit, Kaia Health, Mindstrong Health, Smartpatient gmbh, Ayogo Health Inc., Ginger, Better Therapeutics, Inc., 2Morrow Inc., CANARY HEALTH, Click Therapeutics, Inc., Cognoa, Pear Therapeutics, Inc., Voluntis, Akili Interactive Labs, Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Products in Pipeline

In August 2019, ATENTIV had agreed with Childrens Specialized Hospitals Center. The collaboration tie-up between the two comprises of co-development of a unified behavioral and basic treatment operating system that utilizes the best clinical practices for the conveyance of ATENTIV mynd by primary care clinicians. This collaboration tie-up would increase the companys brand value and market value of the product.

Notable Recent Deals

The players are taking strategic initiatives such as product launch, merger and acquisitions, pending FDA approval in order to gain more market share. For instance, in March 2020 USFDA approved Somryst by Pear Therapeutics for chronic insomnia, which includes algorithm-driven sleep restriction, recommendations, and consolidation. In November 2019, Blue Cross Blue Shield of Minnesota announced to provide reimbursement for Omadas diabetes prevention program to its self-insured payers. In January 2019, Proteus Digital health launched digital oncology medicines to improve the outcomes and treatments of cancer patients, enhancing the companys market growth.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

North America region holds the majority of the share in the digital therapeutic (DTx) market and is expected to witness the CAGR during the forecast period due to increasing number of cases in diabetes. The U.S. has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including digital therapeutic (DTx) products

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

To Know More About COVID-19 Impact On US Digital Therapeutics Market @ https://www.prudentmarkets.com/sample-request/141783/

US Digital Therapeutics Market Analysis Segmentation

By Application:

Diabetes dominated the application segment with a revenue share of over 24% in 2019. Diabetes prevalence is growing rapidly and is linked to blindness, heart attack, kidney failure, stroke, and gangrene in severe cases. Digital therapeutics are being used for the management & prevention of diseases by helping patients change their behavior through constant monitoring, improving their health in the long run. On the basis of application, the U.S. digital therapeutics market is segmented into diabetes, obesity, CVD, respiratory diseases, smoking cessation, CNS diseases, and others.

CNS disease segment is expected to showcase the fastest CAGR over the forecast period owing to the increasing incidence of neurological diseases in the country. Alzheimer's disease, expressive aphasia, degenerative diseases, Huntington's disease, multiple sclerosis, and Parkinson's disease are some of the most common neurological diseases that affect a growing proportion of the U.S. Several digital therapeutics companies have been catering to the specific needs of Central Nervous System (CNS) disease patients to reduce anxiety and keep track of daily activities.

By End-use:

Patients segment dominated the end-use segment with a share of around 33% in 2019. The increased adoption of these tools can be attributed to their added benefits, one of which is effective health management at an affordable cost. In addition, the presence of advanced healthcare IT solutions and supportive government programs in the country are factors expected to further boost the adoption of digital therapeutics by patients. On the basis of end-use, the market is segmented into patients, providers, payers, employers, and others.

Employer segment is expected to be the fastest-growing sub-segment over the forecast period. Employers are focusing on the management of employee healthcare costs, which is expected to drive segment growth. Moreover, growing awareness through employee healthcare programs is expected to propel the adoption of digital therapeutics for maintaining employee wellbeing. The availability of various mHealth apps, such as Vida Health, used by payers, providers, and employers to monitor chronic conditions such as prediabetes, obesity, hypertension, and mental health issues, is another factor expected to propel market growth.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141783/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global US Digital Therapeutics Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global US Digital Therapeutics Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the US Digital Therapeutics market
Chapter 2: Exclusive Summary - the basic information of the US Digital Therapeutics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the US Digital Therapeutics
Chapter 4: Presenting the US Digital Therapeutics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the US Digital Therapeutics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141783/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the US Digital Therapeutics Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.